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Abstract
Cluster detection is an important public health endeavor and in this paper we describe and apply a
recently developed Bayesian method. Commonly-used approaches are based on so-called scan
statistics and suffer from a number of difficulties including how to choose a level of significance
and how to deal with the possibility of multiple clusters. The basis of our model is to partition the
study region into a set of areas which are either “null” or “non-null”, the latter corresponding to
clusters (excess risk) or anti-clusters (reduced risk). We demonstrate the Bayesian method and
compare with a popular existing approach, using data on breast, brain, lung, prostate and
colorectal cancer, in the Puget Sound region of Washington St ate. We address the important issues
of sensitivity to the priors, and the incorporation of covariates. The approach is implemented
within the freely-available R package SpatialEpi.
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Introduction
Cluster detection has a long and controversial history in epidemiology. Unfortunately, only
very rarely have etiological insights been made as a result of investigations into clustering
and clusters1 which has led Rothman2 to call this endeavor into question. Neutra,3 in a
response to Rothman, agreed with a number of his conclusions but believed that
investigation of putative clusters was a necessary part of the public health response; cluster
detection can aid in identification of areas in need of resources or interventions such as
public awareness campaigns and screening.
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In this paper, we describe a new approach to cluster detection, based on a Bayesian model,
and describe the use of the method for cluster detection for five cancers in the Puget Sound
region of Washington State. First, we briefly review a number of the previous approaches to
cluster detection that have been proposed. The most popular approaches are based on scan
statistics, in which a circular window is passed over the study region and the significance of
the observed number of cases in the window is determined. Different proposals base the
circle size on distance,4 the number of cases5 and on the population.6 The latter method has
been extensively refined and forms the basis of the method implemented in the SatScan
software (http://www.satscan.org/.7) The model behind this approach assumes circular
clusters are centered on each of the n area centroids. Circles with varying radii, up to a
maximum that gives a circle with no more than a certain proportion of the total population
(20% is a common choice) are considered. We refer to the circles as (single) zones. Hence,
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any one area will typically fall within a large number of potential zones. Hypothesis testing
is used to determine the significance of clusters by comparing the observed and expected
numbers of disease under the null hypothesis. In the version relevant to the application
considered here, a Poisson likelihood is assumed and a likelihood ratio statistic is calculated
for each zone, with the null corresponding to no clusters. This approach clearly leads to a
large number of dependent tests, and the multiplicity problem is circumvented by evaluating
the significance of only the maximum of the likelihood ratio statistics over all circles, using
a Monte Carlo p-value. The Monte Carlo p-value is computed by comparing the observed
test statistic to a simulated null distribution. Each instance of the simulated null distribution
is constructed by randomly assigning cases to locations under the null hypothesis of no
clusters and computing the test statistic.
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There are a number of drawbacks to the SatScan method. First, as with all frequentist testing
procedures, a fundamental problem is how to interpret the resultant p-value and in particular
choose a threshold below which “significance” should be declared. These difficulties are
well-documented.8–10 A specific problem with p-values is that their interpretation critically
depends on the power of the study. In the context of cluster detection, α = 0.05 was used in
both Kulldorff et al.11 and Jemal et al.12 In the former, breast cancer was examined over 245
counties of the North East of the US with 58,943 deaths and a population of 29,535,216. In
the latter, prostate cancer was examined in males in the United States in 1970–1989 with
71,692 black deaths and 382,204 white deaths amongst the total US male population.
Consequently, the power is very different in the two studies but there is no explicit
consideration of power in the calculation and interpretation of p-values; stated more bluntly,
there is no balancing of type I and type II errors. Intuitively, the p-value significance
threshold should decrease as the sample size increases since the power is increasing, i.e. the
type II error is decreasing, and so the type I error should be decreasing also. A Bayesian
approach to inference acknowledges that the type I and type II errors should go to zero and
provides the machinery to avoid these problems. The standard Bayesian way to evaluate the
evidence in the data for particular null and alternative hypotheses H0 and HA is the Bayes
factor, given by p(data|H0)/p(data|HA). The numerator and denominator of the Bayes factor
represent, respectively, the probability density of the data under the null and alternative
hypotheses, and these calculations depend on the assumed model. The Bayes factor accounts
for power through its denominator, and type I and type II errors are naturally balanced in the
numerator and denominator.9;10;13
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A second difficulty with the SatScan method is how to deal with the possibility of multiple
clusters. The original version of the Kulldorff method, simply compared the p-values of the
second, third, etc. most significant zones using the reference distribution for the maximum
(most likely) cluster, after discarding those with overlap with the first cluster. This approach
is therefore not using the correct reference distribution. The most recent multiple cluster
version of the Kulldorff method14 removes the significant zone, and then repeats the
procedure now using a new reference distribution, until no more significant zones are found.
A deficiency of this approach is that the p-values are not directly comparable since they are
based on different sample sizes and hence have different power. Also, since the procedure
removes significant clusters from the study region at each iteration, the significance of
secondary clusters must be interpreted as conditional on all previously identified significant
Epidemiology. Author manuscript; available in PMC 2016 May 01.
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clusters and not as standalone measures as is desired. Furthermore, one should also consider
the multiple testing aspect of the multiple comparisons that are being made but it would be
very difficult to determine the appropriate error rate of the overall sequential procedure just
described.14
We briefly describe previous approaches to Bayesian cluster detection. The usual smoothing
of rates or relative risks, as implemented in common disease mapping models,15 is not a
good idea, as clusters may be attenuated due to the shrinkage of these models.16 We have
previously described our model for cluster detection17 and illustrated its use with the classic
upstate New York leukemia dataset.18
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In this paper we make some modest extensions to the methodology and demonstrate the
approach in a more extensive application. Specifically, we apply the models to data on
female breast, brain, lung, male prostate, and colorectal cancer, collected in the Puget Sound
region of Washington State between 1996–2005. We choose breast, lung, prostate and
colorectal because they are relatively common, while brain is relatively rare and so was
picked to give an example of the methodology for a rarer cancer. Geographical analyses have
also revealed excess brain cancer mortality in the northwest of the United States,19;20 a
region that contains our study region. The results for breast cancer require careful
interpretation and so we detail these in the main paper, while for brain cancer interpretation
is more straightforward, and we include this in the paper as a contrast. The results for the
remaining three cancer sites are presented in the Supplementary Materials. Our approach is
most similar to that described by Gangnon and Clayton21–23 though with differences
described elsewhere.17 We have implemented our method in the R computing environment
within the SpatialEpi package.
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Brain and Breast Cancer in Western Washington
Study Details
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The Cancer Surveillance System (CSS) collects population-based data on cancer incidence
and survival in n = 887 census tracts in 13 counties in western Washington State: Clallam,
Grays Harbor, Island, Jefferson, King, Kitsap, Mason, Pierce, San Juan, Skagit, Snohomish,
Thurston, and Whatcom counties. The CSS is a project of the Program in Epidemiology,
Division of Public Health Sciences, at the Fred Hutchinson Cancer Research Center
(FHCRC) and is part of the Surveillance, Epidemiology, and End Results (SEER)24 program
of the National Cancer Institute which monitors cancer incidence and survival in
approximately 26% of the US population. The CSS also provides data to the Washington
State Cancer Registry, which monitors cancer incidence in the entire state of Washington.25
In Figure 1 we present a map of the study region with the Seattle and Tacoma metropolitan
regions highlighted with solid and dashed lines respectively and the city of Mount Vernon
marked with a dot. All subsequent maps will include focused maps of both Seattle and
Tacoma. Furthermore all values in legends are grouped by the Jenks natural breaks
classification method which maximizes the variance between the group means while
minimizing the within-group variance of values.26

Epidemiology. Author manuscript; available in PMC 2016 May 01.
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One must bear in mind that two of the chief reasons for carrying out a cluster detection
endeavor are to discover previously unknown exposures or risk factors that are linked with
clusters, or to detect areas with high risks (perhaps due to inaccessibility to health care) in
order to prioritize public health resources and interventions (encouragement of screening, for
example). If we are interested in the former, then adjustment for as many known risk factors
as possible is merited. If we are interested in the latter, then we would not want to adjust for
area-level variables such as income, since this will mask important differences. In the study
we present here, we are interested in detecting areas with high residual (i.e. after adjustment
for risk factors) risk and we report results with and without adjustment for an area-level
measure of income.
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As notation we will use yij to represent the disease count in each area i = 1, …, n and
confounder stratum j = 1,…, J, with Nij the corresponding population size. For each cancer
site, counts of disease incidence yij were obtained for each census tract i = 1,…, 887
stratified by j = 1,…, 180 strata: age (18 age bands: 0–4, 5–9, 10–14, …, 75–79, 80–84,
85+), race (5 categories: White, Black, Asian/Pacific Islander, American Indian and other
including those of two or more races) and gender for brain, lung, and colorectal cancers,
while we only consider women for breast cancer and men for prostate cancer. These disease
counts were combined across years and paired with corresponding population counts Nij
obtained from the 2000 Decennial Census. For each of the five cancer sites, we calculate two
sets of expected numbers in area i, denoted Ei, using internal standardization, at the level of
the census tract. In one set we adjust for age, race, and gender (when required) and in the
other set we additionally adjust for income by quintile. We consider 1999 per capita income
as reported by the American Community Survey at the census tract level only, since age,
race, and gender stratified income data are not available. Our analysis will consider income
through the quintiles defined by cutoffs $18,478, $21,661, $24,825, and $30,161. The
income adjusted reference rates of disease for census tract i are based on disease and
population counts from census tracts in the same income bracket. The Standardized
Morbidity Ratio (SMR) in census tract i is calculated as SMRi = yi/Ei. The SMR is an areabased summary and an estimate of the relative risk in an area, when compared to the
reference rates that were used to construct the expected numbers.
Table 1 displays summaries of the aggregated disease counts yi for all 5 cancers, along with
expected numbers Ei and standardized morbidity ratios SMRi, across areas i = 1,…, n,
unadjusted and adjusted for income. Breast is the most common cancer, followed by
prostate, lung, colorectal, and brain. We now present detailed analyses for brain and breast
cancer, with lung, colorectal and prostate discussed in the Supplementary Materials.
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Initial Analysis for Brain Cancer
Before a cluster detection exercise is carried out it is important to have knowledge of known
risk factors, but the cause of many brain cancer cases is unknown (http://www.cancer.gov/
cancertopics/types/breast). Previously, there was evidence of excess brain cancer mortality in
the northwest United States, as revealed in a cancer mortality atlas,19 and this was followed
up with a formal study of brain cancer mortality across the United States from 1986–1995
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using, amongst other statistical techniques, SatScan.20 This study reported evidence of a
cluster in Washington State.
For our study the expected numbers for brain cancer incidence are displayed in Figure 2,
with the left and right columns being unadjusted and adjusted for income, respectively. The
corresponding SMRs are displayed in Figure 3. Compared to the other cancers the expected
numbers are relatively small, but the SMRs show large variability, which may of course be
attributed to sampling variability due to the relatively small expected numbers for many
census tracts. A plot of (log) SMRs versus income quintile (both with and without
adjustment for income), provided in the Supplementary Materials, shows very little evidence
of a census tract level association between relative risk and income.
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We present results of the multiple cluster Kulldorff method14 using both income unadjusted
and adjusted expected counts. We set the highest proportion of the population a zone can
contain at 15%, the α-cutoff to declare significance at α = 0.05 and simulate 9,999 Monte
Carlo realizations under the null hypothesis of no clusters. The results are presented in
Figure 4. For both income unadjusted and adjusted expected counts, there are no clusters
that are significant at the 5% level.
Initial Analysis for Breast Cancer

Author Manuscript

We first briefly summarize the risk factors for breast cancer, leaning heavily on http://
www.cancer.gov/cancertopics/types/breast. The lifetime risk for developing breast cancer for
women in the United States is approximately 1 in 8. Risk factors for breast cancer include
genetic alterations, dense breasts, exposure to estrogen (early menstruation, late menopause,
no pregnancy or late pregnancy), family history of breast cancer, alcohol, race (breast cancer
is diagnosed more in white women) and obesity. Protective factors for breast cancer include
less exposure to estrogen (for example through early pregnancy, breast-feeding, increased
number of births and increased duration of breast feeding) and exercise.

Author Manuscript

The geographical distribution of breast cancer risk has received a reasonable amount of
interest with Kulldorff et al.11 providing an early example of the application of a scan
statistic to breast cancer, with numerous other studies following. For example, scan statistics
have been used to detect clusters for breast cancer in Massachusetts,27 Texas,28
Connecticut,29 and across all counties in the United States30. An interpretation of
geographical variation across the United States has also been carried out,31 with a major
conclusion being that at large scales at least, there are differences in presentation (i.e. stage)
by region and by race. A large number of geographical analyses have examined the
association between clusters and environmental pollution sources (see for example Jacquez
and Greiling32 and references there-in). Interest in cluster detection for breast cancer extends
beyond the United States, for example, breast cancer has been examined geographically in
Japan, using the Kulldorff scan statistic.33
The expected numbers for breast cancer are displayed in Figure 5 with the SMRs displayed
in Figure 6. The expected numbers for breast cancer are far greater than for brain and while
the SMRs for breast cancer have roughly the same range as with brain, the former are more
accurately estimated given the larger expected counts. In the Supplementary Materials we
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plot the (log) SMRs (without adjustment for income) versus income quintiles, and we see
that there is a negative association, with areas in higher income quintiles having higher
relative risks. This is not unexpected given the above risk factors for breast cancer since we
would expect women living in areas with low average income to have more and earlier
pregnancies and a greater duration of breast feeding.
Figure 7 gives the results of the scan statistic both without and with adjustment for income.
Without income there is one very large cluster in Seattle that has a significance level <
0.0001, with three additional clusters, one to the west of Seattle, one in Tacoma and a single
census tract near Mt Vernon in the north of the study region. With adjustment for income
there are three areas, two in Tacoma with estimated relative risks of 5.671 and 2.320, and a
third consisting of the single census tract near Mt Vernon with an estimated relative risk
1.146.
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A Bayesian Cluster Detection Model
As with the scan statistic method, suppose the study region is partitioned into i = 1,…, n
areas, which are typically administrative subdivisions of a region such as census tracts, zip
codes, or counties. Let θi be the relative risk in area i, where relative is with respect to the
reference rates for disease that were used to construct the expected numbers. The
Supplementary Materials contain a mathematical description of our model; here we give an
explanation in heuristic terms.
Configurations as Data Models

Author Manuscript

Following Kulldorff6 we define what we refer to as single zones: contiguous collections of
areas that form “jagged circles.” We create the list of single zones by sequentially
aggregating neighboring areas, by taking each area in turn, and continually adding the areas
whose centroids are closest to the area center. This procedure is continued until the zone’s
population reaches a pre-specified maximum allowable proportion of the total study region’s
population, typically under 50%. Our cluster detection model treats each of the N1 resulting
single zones as a potential cluster (region of high residual risk) or anti-cluster (region of low
residual risk).
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First, suppose that there exists no more than one cluster/anti-cluster in the study region. We
assume the data can be explained by N1 + 1 possible configurations, where each
configuration can be viewed as a model for y1,…, yn. The first is a null configuration of no
clusters/anti-clusters which assumes that all areas in the study region have “null” relative
risks that are close to 1. The remaining N1 configurations assume that one and only one
single zone is a cluster/anti-cluster where within a single zone all areas share a common
“non-null” relative risk, i.e., elevated or lowered risk, while all areas outside the single zone
have null relative risks. In null areas we do not force the relative risks to be exactly 1, but
rather assume that the relative risks arise from a “narrow” distribution that is concentrated
close to 1, reflecting the fact that even with true null risk unmeasured confounders and data
anomalies can still yield some variability around 1. In contrast, for non-null areas within a
single zone, we assume they share a common relative risk that arises from a “wide”
distribution that is more diffuse, though still centered around 1. An illustrative example of
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null/narrow and non-null/wide relative risk distributions using two gamma distributions is
given in Figure 8 where the respective 95% intervals are marked with dashed lines. We
discuss the specification of the gamma distribution parameters in the next section.
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We now describe how the framework is extended to allow for the possibility of more than
one cluster/anti-cluster. Let Nj for j = 2,…, J be the number of combinations of j single
zones that do not overlap, up to a pre-specified maximum of non-null regions J (hence, the
maximum number of clusters/anti-clusters is J). For our examples in this paper we specify a
maximum of J = 7 clusters/anti-clusters in the study region. Given that we only consider
non-overlapping single zones, we assume that the relative risks in non-overlapping single
zones are independent and arise from the wide distribution and, as with the single cluster/
anti-cluster case, all areas not included in a single zone have null relative risks. These
configurations are the (discrete) unknown parameter of our cluster detection model; we
denote this parameter c. The null configuration is denoted c = {0, 1} and c = {j, k} denotes a
non-null configuration k consisting of j single zones for k = 1,…, Nj. An example of a
configuration consisting of j = 2 single zones can be found in the Supplemental Materials.
The posterior probability Pr(c|y1,…, yn) for all configurations c is a summary of interest of
our model and is computed using Bayes theorem.
There are 1 + N1 + N2 + … + NJ possible configurations, that is models for the data, to
consider. This value is very large in typical applications. For example, for the SEER data
there are n = 887 census tracts and N1 = 117, 006 single zones. The number of multiple
single zone configurations then grows quickly and we can only estimate, rather than
enumerate, these quantities. For example

,

, and
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. Hence, it is not computationally feasible to enumerate all possible
configurations and compute their exact posterior probabilities. Therefore, as an alternative
we search through the space of all possible configurations using a Markov chain Monte
Carlo (MCMC) algorithm to approximate all posterior probabilities. Details of the
computation are in the Supplementary Materials, and the method is implemented within the
SpatialEpi package within the R computing environment.
Likelihood and Prior
A typical choice of model for rare diseases is to assume, for a generic region with count y, y|
θ ~ Poisson(Eθ) where θ is the relative risk associated with the region and E is the expected
number of disease.34 By assuming a conjugate Gamma(a, b) prior on θ with shape and rate

Author Manuscript

parameters (a, b) the marginal likelihood Pr(y) is Negative Binomial
. As
previously described we have two specifications of the Gamma parameters (a, b)
corresponding to the null and non-null distribution of relative risks described earlier: a
narrow specification (an, bn) and a wide specification (aw, bw). These values are chosen by
specifying two θ points with a pair of characteristics. In particular, we set the mode of the
distribution to be θ = 1, a value reflecting no increased nor decreased risk, and we specify
the 95th percentile of the distribution (see the Supplementary Materials for further
discussion). For example, specifying 95th percentiles of 1.03 and 4, we have Gamma
parameters of (an, bn) = (2976.30, 2977.30) and (aw, bw) = (2.31, 1.31) respectively, and
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these are the choices shown in Figure 8. Furthermore the points (θL, θH) at which the two
gamma distributions intersect are used as thresholds to declare an area’s relative risk as
being elevated/reduced since outside the interval defined by these two points the wide
specification has higher density. For the above choices of gamma priors the crossover points
are (θL, θH) = (0.949, 1.052). For the null configuration c = {0, 1} all disease counts yi are
independent with relative risks θi from the narrow specification for i = 1,…, n. For all nonnull configurations c = {j, k}, since the j single zones are independent, the likelihood for the
data is the product of the likelihoods associated with the j single zones and the likelihoods of
all remaining null areas.
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We require a prior on the configurations c = {j, k}, with the number of clusters/anti-clusters
being j, and k indexing the configurations for that j. We assign a mass of π0 = Pr(c = {0, 1})
for the prior on the null, with a typical figure being 0.95 or 0.99, since a priori we expect the
chance of clusters to be small. The remaining mass of 1 − π0 needs to be spread over the
remaining configurations c = {j, k} for j = 1,…, J, k = 1,…, Nj. Within each j, i.e. for each
number of clusters/anti-clusters, we take each configuration to be equally likely, i.e.
, where τ is the number of clusters/anti-clusters. It only remains to
distribute 1 − π0 over j = 1,…, J. Recall that each set of j clusters within a particular
configuration must be non-overlapping. For a particular j, let qj be the probability that a
randomly selected set of j clusters are non-overlapping. For example, for j = 2, q2 is the
probability that two of the randomly selected N2 possible single zones are non-overlapping.
One may then take
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so that the marginal prior on the number of clusters/anti-clusters is implied by our choice of
the prior on the null, and the set of decreasing probabilities on increasing numbers of
clusters/anti-clusters. This produces a set of prior probabilities that decrease monotonically
from J = 1, in a relatively natural fashion. As an illustration, with the Puget Sound study
geography, the probabilities for j = 0,…, J we obtain from this prescription are 0.950, 0.034,
0.013, 0.003, 2.941 × 10−4, 1.993 × 10−5, 1.027 × 10−6, and 3.029 × 10−8. There are many
ways we could specify the set of J + 1 probabilities, and we encourage examining the
sensitivity of the results to different choices (see later for examples). For example, we may
also spread the probability of a non-null configuration 1 − π0 equally over j = 1,…, J.
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Posterior Probabilities
Each configuration c = {j, k} for j ≥ 1 is made up of j single, non-overlapping zones. The
posterior probability for the null configuration is simply
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where i ∈ c denotes all the areas included in any of j single zones that form configuration c =
{j, k}. In other words, all areas included in any of the single zones follow the non-null model
where areas within a common single zone share a common relative risk from the wide prior
and all remaining areas are independent with relative risks from the narrow prior. See
Supplementary Materials for more details on this derivation.
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It is difficult to make statements on the occurrence of clusters/anti-clusters based on the
posterior probabilities of individual configurations given the large number of configurations
to consider, many of which are only minor variations of each other. As an alternative
measure, we may calculate the posterior probability of cluster membership for each area i.
For a non-null configuration c = {j, k} with area i included in one of the j single zones, we
evaluate the posterior probability of that single zone’s relative risk being “elevated”, where
elevated indicates higher than the high crossover point θH. Analogously we can define the
posterior probability of anti-cluster membership for area i using the lower crossover point
θL. Furthermore, before seeing the data we can evaluate the prior probability of cluster
membership for each area i using the prior distribution of the relative risk. Another summary
measure of interest is the posterior probability of the number of clusters/anti-clusters in the
data. For τ = j clusters/anti-clusters we have

Author Manuscript

which sums the posterior probabilities of all configurations with τ single zones. Of particular
interest will be the τ = 0 case corresponding to no clusters/anti-clusters.

Results
Bayesian Analysis for Brain Cancer

Author Manuscript

We perform the Bayesian analyses with the maximum proportion of the population a single
zone can contain being 15%, wide (aw, bw) = (2.31, 1.31) and narrow (an, bn) = (2976.30,
2977.30) specifications of the Gamma parameters, as shown in Figure 8, a prior probability
π0 = 0.95 of no clusters/anti-clusters, and a maximum number of clusters/anti-clusters of J =
7.
In Figure 9 we present the results for brain cancer using the income unadjusted expected
counts in the left column and income adjusted expected counts in the right column. The
results are not inconsistent with the multiple cluster scan statistic results, with both analyses
giving very little evidence of brain cancer clusters, with the highest posterior probabilities of
cluster membership being less than 0.006. In Figure 10 we present a barplot of the prior
probabilities of clusters/anti-clusters for j = 0,…, 7, along with the posteriors probabilities
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with and without adjustment for income. The posterior probability of no clusters/anticlusters is approximately 0.99 in both cases, which is higher than the prior probability of π0
= 0.95. In Figure 11 we present a plot of the sensitivity of the posterior probabilities on the
number of clusters/anti-clusters as a function of the specification for π0, the prior mass
placed on the null configuration. The calculations for this plot can be carried out without rerunning the analysis (for details, see Supplemental Materials). Tracing horizontal lines
across the plot give the set of posterior probabilities for that π0 value. There is a relative
insensitivity to π0 in both plots, with only very low (and unrealistic) values of π0 giving even
a single cluster/anti-cluster. In the Supplementary Materials we further investigate prior
sensitivity to the specification of the narrow/wide components and an alternative prior on the
number of clusters/anti-clusters (uniform on 1,…, J). There is little sensitivity to the
different priors, and for brain cancer we conclude there is little evidence for clusters in the
Puget Sound region, at the geographical scale at which we have data available.

Author Manuscript

Bayesian Analysis for Breast Cancer

Author Manuscript

In Figure 12 we present the results for breast cancer using the income unadjusted expected
counts in the left column and income adjusted expected counts in the right column. We
observe a large number of areas with high posterior probability of cluster membership in
Seattle and the Kirkland, Redmond, and Bellevue suburbs. These probabilities diminish in
magnitude when using the income adjusted expected counts, indicating that a large
component of the high relative risks in these areas has been absorbed by income. As we see
in Figure 13, there is a large mass of posterior probability (94%) of j = 4, 5 clusters/anticlusters when ignoring income information that shifts towards j = 0 once income
information is incorporated. After adjustment there is 73% posterior probability on the null,
with the majority of the remaining probability falling on 1 or 2 clusters/anti-clusters. There
remains a single area in Tacoma with a relatively high posterior probability of 0.201. The
second and third clusters indicated by the scan statistic method (Figure 7) do not have high
posterior probabilities associated with them. The heat map in Figure 14 illustrates the
sensitivity of the posterior on the number of clusters/anti-clusters to the prior on the null, π0.
In the case of breast cancer adjusted for income, the results are almost entirely insensitive to
the choice of π0. After incorporating income however, the posterior probabilities now vary
more depending on the choice of π0. Since higher values of π0 correspond to higher prior
skepticism at the existence of clusters/anti-clusters, the bulk of the posterior probabilities
shifts towards j = 0. Additional summaries under different priors are given in the
Supplementary Materials.
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As discussed earlier, there are many well-documented risk factors for breast cancer, and we
would expect many of these risk factors to have geographical structure. Unfortunately, as is
usually the case in studies such as this based on aggregated count data, information on these
risk factors is not available. Many of these risk factors will be associated with income, which
explains why the number of clusters decreased when an area-level measure of income was
included. This adjustment is clearly very crude and further analyses of breast cancer
incidence in our study region would preferably be carried out using individual-level data
with information on risk factors. Another important issue for breast cancer is screening.
Screening rates vary geographically and we would expect those areas with high screening

Epidemiology. Author manuscript; available in PMC 2016 May 01.

Kim and Wakefield

Page 11

Author Manuscript

rates to have more breast cancer diagnoses even if the underlying risk is the same as areas
with lower screening rates. This is supported by a plot of SMR versus screening rate (at the
county level), included in the Supplementary Materials.

Discussion

Author Manuscript

Much like the multiple cluster Kulldorff method,6 our Bayesian model constructs a set of
single zones and treats each of them as potential clusters/anti-clusters. However, our method
allows us to formally model the existence of more than one cluster by combining a number j
of single zones to form configurations. These configurations, in particular the null
configuration of no clusters/anti-clusters, are used as models to explain the observations and
are the unknown parameters of our model to which we associate prior and posterior
probabilities. By taking a Bayesian approach, our model accounts for sample size and
power.9;10;13
While our method yields qualitatively similar results as the multiple cluster Kulldorff
method, since our model allows for simultaneous modeling of more than one cluster/anticluster we obtain probabilities of cluster membership which are directly comparable
between areas. This is in contrast to the multiple cluster Kulldorff method which considers
only the most significant cluster, drops (if any) the most significant cluster, and iterates the
procedure. The resulting p-values are difficult to interpret as they are sequential in nature
and all resulting claims of significance based on them do not incorporate notions of sample
size or power.

Author Manuscript

The computation for the Bayesian model is far greater than that for typical scan statistics,
but the biggest difficulty in routinely using the Bayesian approach we have described is the
need to specify prior distributions. In practice, as we have illustrated for brain and breast
cancer, one should carry out sensitivity to the prior distribution. We would encourage the use
of Kulldorff’s scan statistic, in particular at the early stages of a cluster detection exercise,
but we believe that the Bayesian approach we have described provides valuable additional
information, foremost explicit posterior probabilities of cluster membership for each area,
and a coherent way of handling multiple clusters.
The methods described in the paper is implemented in the R package SpatialEpi. An
example of its application to the often studied upstate New York leukemia dataset can be
found at https://github.com/rudeboybert/SpatialEpi.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Study region with Seattle (solid line) and Tacoma (dashed line) metropolitan regions
highlighted and the city of Mount Vernon marked with a dot.
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Figure 2.

Maps of income unadjusted (left column) and income adjusted (right column) expected
counts of brain cancer.
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Figure 3.

Maps of income unadjusted (left column) and income adjusted (right column) standardized
morbidity ratios for brain cancer.
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Figure 4.

Maps of income unadjusted (left column) and income adjusted (right column) multiple
cluster scan statistic results for brain cancer.
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Figure 5.

Maps of income unadjusted (left column) and income adjusted (right column) expected
counts of breast cancer.
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Figure 6.

Maps of income unadjusted (left column) and income adjusted (right column) standardized
morbidity ratios for breast cancer.
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Figure 7.

Maps of income unadjusted (left column) and income adjusted (right column) multiple
cluster scan statistic results for breast cancer.

Author Manuscript
Epidemiology. Author manuscript; available in PMC 2016 May 01.

Kim and Wakefield

Page 21

Author Manuscript
Figure 8.
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Wide and narrow distributions on the relative risk. Under the null (no clusters/anti-clusters),
relative risks θ are assumed to arise from the narrow prior, so that there is still a small
amount of “wobble” about 1. Under the alternative (at least one cluster/anti-cluster), the
relative risks are assumed to arise from the wide prior, so that there is greater variation. Note
that the θ scale is logarithmic.
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Figure 9.

Maps of income unadjusted (left column) and income adjusted (right column) posterior
probabilities of brain cancer cluster membership.
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Figure 10.

Prior/posterior probabilities of the number of brain cancer clusters/anti-clusters.
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Sensitivity of posterior probabilities of the number of brain cancer clusters/anti-clusters to
π0. Tracing horizontal lines across the plot give the set of posterior probabilities for that π0
value.
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Figure 12.

Maps of income unadjusted (left column) and income adjusted (right column) posterior
probabilities of breast cancer cluster membership.
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Figure 13.

Prior/posterior probabilities of the number of breast cancer clusters/anti-clusters.
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Sensitivity of posterior probabilities of the number of breast cancer clusters/anti-clusters to
π0. Tracing horizontal lines across the plot give the set of posterior probabilities for that π0
value.
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